MDWD - MediWound Ltd.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
6.08
+0.02 (+0.33%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close6.06
Open6.10
Bid5.94 x 900
Ask6.70 x 800
Day's Range6.00 - 6.18
52 Week Range3.56 - 7.35
Volume4,783
Avg. Volume30,540
Market Cap165.247M
Beta (3Y Monthly)0.68
PE Ratio (TTM)N/A
EPS (TTM)-0.85
Earnings DateJul 28, 2017 - Jul 31, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.60
Trade prices are not sourced from all markets
  • GlobeNewswire24 days ago

    MediWound Awarded Additional BARDA Contract Valued Up to $43 Million for Development of NexoBrid® for Sulfur Mustard Injuries

    MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the U.S. Biomedical Advanced Research and Development Authority (BARDA) has awarded MediWound a new contract to develop NexoBrid® for the treatment of Sulfur Mustard injuries as part of BARDA preparedness for mass casualty events.

  • GlobeNewswirelast month

    NexoBrid® Receives Marketing Authorization from Russia's Ministry of Health

    MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced receipt of authorization from the Ministry of Health in Russia to market and distribute NexoBrid® for the removal of dead or damaged tissue, known as eschar, in adults with deep partial and full-thickness thermal burns. Genfa Medica S.A., MediWound’s exclusive distribution partner in Russia, received the marketing authorization and intends to launch NexoBrid in Russia in the first half of 2019.

  • MediWound (MDWD) Reports Q2 Loss, Tops Revenue Estimates
    Zacks2 months ago

    MediWound (MDWD) Reports Q2 Loss, Tops Revenue Estimates

    MediWound (MDWD) delivered earnings and revenue surprises of 25.00% and 7.96%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press2 months ago

    MediWound: 2Q Earnings Snapshot

    The Yavne, Israel-based company said it had a loss of 15 cents per share. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was ...

  • GlobeNewswire2 months ago

    MediWound Reports Second Quarter 2018 Financial Results

    Completion of enrollment of Phase 3 DETECT Study of NexoBrid ® Strategic discussions advancing with multiple parties. Conference call begins today at 8:30 a.m. Eastern Time. YAVNE, Israel, Aug. 07, 2018-- ...

  • ACCESSWIRE2 months ago

    MediWound Ltd. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 7, 2018 / MediWound Ltd. (NASDAQ: MDWD ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 7, 2018 at 8:30:00 AM Eastern Time. ...

  • GlobeNewswire3 months ago

    MediWound to Host Second Quarter 2018 Financial Results Conference Call on August 7 at 8:30 a.m. Eastern Time

    MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the Company will release its financial results for the second quarter ended June 30, 2018 at 7:00 am Eastern time on Tuesday, August 7, 2018. Following the release, MediWound's management will host a conference call for the investment community beginning at 8:30 a.m. Eastern time to discuss the financial results and to answer questions. Shareholders and other interested parties may participate in the conference call by dialing 800-289-0438 (in the U.S.) 1809 212 883 (Israel), or 323-794-2423 (outside the U.S. & Israel) and entering passcode 6005908.

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of MDWD earnings conference call or presentation 10-May-18 12:30pm GMT

    Q1 2018 Mediwound Ltd Earnings Call

  • Associated Press5 months ago

    MediWound: 1Q Earnings Snapshot

    On a per-share basis, the Yavne, Israel-based company said it had a loss of 17 cents. The results met Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research ...

  • ACCESSWIRE7 months ago

    Today’s Research Reports on Trending Tickers: BioPharmX and MediWound

    NEW YORK, NY / ACCESSWIRE / March 21, 2018 / Stock markets rallied Tuesday on gains from the energy and consumer discretionary sector. Wall Street appears to be eagerly awaiting details from the Federal ...

  • Thomson Reuters StreetEvents7 months ago

    Edited Transcript of MDWD earnings conference call or presentation 19-Mar-18 12:30pm GMT

    Q4 2017 Mediwound Ltd Earnings Call

  • Associated Press7 months ago

    MediWound reports 4Q loss

    The Yavne, Israel-based company said it had a loss of 9 cents per share. Losses, adjusted to account for discontinued operations, came to 8 cents per share. The results topped Wall Street expectations. ...

  • ACCESSWIRE7 months ago

    MediWound Ltd. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 19, 2018 / MediWound Ltd. (NASDAQ: MDWD ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 19, 2018, at 8:30 AM Eastern Time. To ...

  • Thomson Reuters StreetEvents11 months ago

    Edited Transcript of MDWD earnings conference call or presentation 16-Nov-17 1:30pm GMT

    Q3 2017 Mediwound Ltd Earnings Call